Newsroom (64)
Articles
01/21/2024
Israel’s Immunai could be the secret weapon to faster drug approvals
Publications
01/12/2024
Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function
Publications
10/22/2023
1883MO – MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC)
Publications
08/01/2023
Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes
Publications
05/15/2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Publications
08/02/2022
Quantifying the Reproducibility of Cell-Perturbation Experiments
Publications
07/26/2022
Neural Design for Genetic Perturbation Experiments
Publications
06/18/2022